|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.7391 - 0.7391|
|52 Week Range||0.2130 - 0.8820|
|Beta (5Y Monthly)||1.27|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar. 08, 2016|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engaged Independent Trading Group Inc. ("ITG") to provide market-making services to the Company. ITG will trade the Company's common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE") and other marketplaces, ...
10, 2021 /CNW/ -- AirConsole launches a hot new quiz for couples that are caught in lockdown for Valentine's Day 2021 due to the ongoing pandemic. This year, you will truly get to know your partner.
Toronto, Ontario--(Newsfile Corp. - February 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab") announces that it has granted, in accordance with the Company's stock option plan, an aggregate of 50,000 options to purchase common shares of the Company to a consultant of the Company. Each option is exercisable at a price of $0.80 per share for a period of two years, expiring February 3, 2023.About ...